- Dr Reddy’s Laboratories Q3 Results | Net profit up 3% to ₹1,413 crore, revenue up 16%; misses estimates CNBCTV18
- Indian drugmaker Dr Reddy’s shares slide after Q3 profit miss Mint
- Reduce Dr. Reddy’s Laboratories; target of Rs 1335: Prabhudas Lilladher Moneycontrol
- Jefferies, Nuvama cut target price for Dr Reddy’s. 3 thing to know… The Financial Express
- Explained: Why Dr Reddy’s share price cracked 6% in early trade India Today
Dr Reddy’s Laboratories Q3 Results | Net profit up 3% to ₹1,413 crore, revenue up 16%; misses estimates CNBCTV18Indian drugmaker Dr Reddy’s shares slide after Q3 profit miss MintReduce Dr. Reddy’s Laboratories; target of Rs 1335: Prabhudas Lilladher MoneycontrolJefferies, Nuvama cut target price for Dr Reddy’s. 3 thing to know… The Financial ExpressExplained: Why Dr Reddy’s share price cracked 6% in early trade India Today Top stories – Google News